Foreign funds eager to acquire Korean pharmaceutical firms

The merger and acquisition of Korea’s small- and mid-sized companies is talk of town nowadays amid steep Korean won’s slide.

A number of potential bidders who want these companies will remain a lucrative business in the years to come.

Some foreign funds have expressed strong interest and determination to acquire a small company worth 15 billion won.

“Such drives seem inevitable as fore...